These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2360450)
41. Enoxacin distribution in human tissues after multiple oral administration. Malmborg AS; Rannikko S J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902 [TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days. Dobbs BR; Gazeley LR; Stewart IA; Edwards IR J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903 [TBL] [Abstract][Full Text] [Related]
43. Implication of surfactant apoprotein in otitis media with effusion. Yamanaka N; Kobayashi K; Kataura A; Kuroki Y; Akino T Ann Otol Rhinol Laryngol; 1991 Oct; 100(10):835-40. PubMed ID: 1952651 [TBL] [Abstract][Full Text] [Related]
44. Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years. Paradise JL; Dollaghan CA; Campbell TF; Feldman HM; Bernard BS; Colborn DK; Rockette HE; Janosky JE; Pitcairn DL; Kurs-Lasky M; Sabo DL; Smith CG Pediatrics; 2003 Aug; 112(2):265-77. PubMed ID: 12897272 [TBL] [Abstract][Full Text] [Related]
45. The efficacy of pulse-dosed antibiotic therapy in the management of persistent otitis media with effusion. Donaldson JD; Martin GF; Maltby CC; Seywerd EB J Otolaryngol; 1990 Jun; 19(3):175-8. PubMed ID: 2192073 [TBL] [Abstract][Full Text] [Related]
46. Effect of steady-state enoxacin on single-dose pharmacokinetics of roflumilast and roflumilast N-oxide. Lahu G; Nassr N; Herzog R; Elmlinger M; Ruth P; Hinder M; Huennemeyer A J Clin Pharmacol; 2011 Apr; 51(4):586-93. PubMed ID: 20466871 [TBL] [Abstract][Full Text] [Related]
47. Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. Florea A; Zwart JE; Lee CW; Depew A; Park SK; Inman J; Wareham R; Johnson K; John E; Wall GM; Jung T Acta Otolaryngol; 2006 Sep; 126(9):910-5. PubMed ID: 16864486 [TBL] [Abstract][Full Text] [Related]
48. Assessment of middle ear effusion and audiological characteristics in young children with adenoid hypertrophy. Ren DD; Wang WQ Chin Med J (Engl); 2012 Apr; 125(7):1276-81. PubMed ID: 22613601 [TBL] [Abstract][Full Text] [Related]
49. Effect of gastric acidity on enoxacin absorption. Lebsack ME; Nix D; Ryerson B; Toothaker RD; Welage L; Norman AM; Schentag JJ; Sedman AJ Clin Pharmacol Ther; 1992 Sep; 52(3):252-6. PubMed ID: 1526081 [TBL] [Abstract][Full Text] [Related]
50. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. Krause PJ; Owens NJ; Nightingale CH; Klimek JJ; Lehmann WB; Quintiliani R J Infect Dis; 1982 Jun; 145(6):815-21. PubMed ID: 7200999 [TBL] [Abstract][Full Text] [Related]
51. Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections. Patel SS; Spencer CM Drugs; 1996 Jan; 51(1):137-60. PubMed ID: 8741236 [TBL] [Abstract][Full Text] [Related]
52. Immunologic aspects of otitis media with effusion. Mogi G; Watanabe N; Maeda S; Umehara T Acta Otorhinolaryngol Belg; 1983; 37(1):5-21. PubMed ID: 6351530 [TBL] [Abstract][Full Text] [Related]
53. Language, speech sound production, and cognition in three-year-old children in relation to otitis media in their first three years of life. Paradise JL; Dollaghan CA; Campbell TF; Feldman HM; Bernard BS; Colborn DK; Rockette HE; Janosky JE; Pitcairn DL; Sabo DL; Kurs-Lasky M; Smith CG Pediatrics; 2000 May; 105(5):1119-30. PubMed ID: 10790473 [TBL] [Abstract][Full Text] [Related]
54. Enoxacin penetration into human prostatic tissue. Bergeron MG; Roy R; Lessard C; Foucault P Antimicrob Agents Chemother; 1988 Sep; 32(9):1433-4. PubMed ID: 3196004 [TBL] [Abstract][Full Text] [Related]
55. Low dose macrolide administration for long term is effective for otitis media with effusion in children. Chen K; Wu X; Jiang G; Du J; Jiang H Auris Nasus Larynx; 2013 Feb; 40(1):46-50. PubMed ID: 22673738 [TBL] [Abstract][Full Text] [Related]
56. Prognosis of acute otitis media: factors associated with poor outcome. Jero J; Virolainen A; Virtanen M; Eskola J; Karma P Acta Otolaryngol; 1997 Mar; 117(2):278-83. PubMed ID: 9105466 [TBL] [Abstract][Full Text] [Related]
57. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. Davies BI; Maesen FP; Teengs JP J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325 [TBL] [Abstract][Full Text] [Related]
58. Penetration of clarithromycin and its 14-hydroxy metabolite into middle ear effusion in children with secretory otitis media. Sundberg L; Cederberg A J Antimicrob Chemother; 1994 Feb; 33(2):299-307. PubMed ID: 8182011 [TBL] [Abstract][Full Text] [Related]
59. Tissue penetration and clinical efficacy of enoxacin in urinary tract infections. Childs SJ Clin Pharmacokinet; 1989; 16 Suppl 1():32-7. PubMed ID: 2653693 [TBL] [Abstract][Full Text] [Related]
60. Beta-trace protein in pediatric otitis media with effusion. Bachmann-Harildstad G; Müller R; Michel O Int J Pediatr Otorhinolaryngol; 2014 Apr; 78(4):659-62. PubMed ID: 24560237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]